Neurofibromatosis 1 phenotype associated to malignant peripheral nerve sheath tumours: a case‐control study

Background  Malignant peripheral nerve sheath tumours (MPNSTs) are the main cause of death in neurofibromatosis 1 adult patients.

[1]  J. Ragoussis,et al.  Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989 , 2013, European Journal of Human Genetics.

[2]  J. Lefaucheur,et al.  At-Risk Phenotype of Neurofibromatose-1 Patients: A Multicentre Case-Control Study , 2011, Orphanet journal of rare diseases.

[3]  S. Lyonnet,et al.  Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France , 2011, Orphanet journal of rare diseases.

[4]  I. Bièche,et al.  Identification of Genes Potentially Involved in the Increased Risk of Malignancy in NF1-Microdeleted Patients , 2011, Molecular medicine.

[5]  P. Berbis,et al.  NF-1Score: a prediction score for internal neurofibromas in neurofibromatosis-1. , 2010, The Journal of investigative dermatology.

[6]  E. Pasmant,et al.  Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1. , 2009, Human molecular genetics.

[7]  D. Droz,et al.  Orodental phenotype and genotype findings in all subtypes of hypophosphatasia , 2009, Orphanet journal of rare diseases.

[8]  P. Wolkenstein,et al.  Histopathologically dysplastic neurofibromas in neurofibromatosis 1: diagnostic criteria, prevalence and clinical significance , 2008, The British journal of dermatology.

[9]  J. Zeller,et al.  Association between benign and malignant peripheral nerve sheath tumors in NF1 , 2005, Neurology.

[10]  J. Zeller,et al.  Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1 , 2005, The British journal of dermatology.

[11]  K. Khosrotehrani,et al.  Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: A cohort study of 703 patients , 2005, American journal of medical genetics. Part A.

[12]  K. Khosrotehrani,et al.  Clinical risk factors for mortality in patients with neurofibromatosis 1: a cohort study of 378 patients. , 2003, Archives of dermatology.

[13]  D. Evans,et al.  Malignant peripheral nerve sheath tumours in neurofibromatosis 1 , 2002, Journal of medical genetics.

[14]  D. Gutmann,et al.  International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. , 2002, Cancer research.

[15]  K. Leroy,et al.  Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients. , 2001, Archives of dermatology.

[16]  Q. Yang,et al.  Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. , 2001, American journal of human genetics.

[17]  A. King,et al.  Malignant peripheral nerve sheath tumors in neurofibromatosis 1. , 2000, American journal of medical genetics.

[18]  J. Towbin,et al.  Clinic-based study of plexiform neurofibromas in neurofibromatosis 1. , 2000, American journal of medical genetics.

[19]  J. Woodruff.  Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis. , 1999, American journal of medical genetics.

[20]  M. Zöller,et al.  Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden. , 1995, Acta dermato-venereologica.

[21]  A. Paller.  Neurofibromatosis: Phenotype, Natural History, and Pathogenesis , 1993 .

[22]  S. Huson,et al.  Von Recklinghausen neurofibromatosis: a clinical and population study in south-east Wales , 1988 .